Assignee
TUNE THERAPEUTICS INC
US·6 granted patents·8 pending applications·7 citations·filing 2022–2025
Top patents by PatentIndex Score
14 records- 0192US12252692B2Compositions, systems, and methods for regulation of hepatitis B virus through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2023·Granted Mar 18, 2025·2 cites·25 claims
- 0292US12221608B2Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2023·Granted Feb 11, 2025·2 cites·26 claims
- 0392US12098399B2Compositions, systems, and methods for epigenetic regulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene expressionTUNE THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·3 cites·8 claims
- 0488US12398394B2Compositions, systems, and methods for regulation of Hepatitis B virus through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2024·Granted Aug 26, 2025·0 cites·30 claims
- 0588US12325857B2Compositions, systems, and methods for regulation of Hepatitis b virus through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2024·Granted Jun 10, 2025·0 cites·30 claims
- 0679US2025270559A1Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0779US2025320498A1Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0876US12325858B1Compositions, systems, and methods for regulation of Hepatitis B virus through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2025·Granted Jun 10, 2025·0 cites·30 claims
- 0972US2024401014A1Compositions, systems, and methods for reducing low-density lipoprotein through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1062US2026097119A1Compositions, systems, and methods for modulating t cell functionTUNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1161US2024254483A1Compositions and methods for modulating expression of frataxin (fxn)TUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1257US2024252684A1Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2)TUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1354US2025134999A1Compositions, systems, and methods for programming t cell phenotypes through targeted gene activationTUNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1454US2025154503A1Compositions, systems, and methods for programming t cell phenotypes through targeted gene repressionTUNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TUNE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →